A potentially ground-breaking vaccine to treat early bowel cancer is set to go on trial in England and Australia.
The vaccine will be administered to patients before surgery in the hopes of causing the body to attack the cancer and making surgery less invasive.
The trial will be run by the Cancer Research UK Southampton Clinical Trials Unit and will enroll 44 patients over an 18 month period.